Mcdonald Capital Investors Incca Lowers stake in Core Laboratories N.V. (CLB)

Core Laboratories N.V. (CLB) : Mcdonald Capital Investors Incca reduced its stake in Core Laboratories N.V. by 25.63% during the most recent quarter end. The investment management company now holds a total of 231,783 shares of Core Laboratories N.V. which is valued at $26,305,053 after selling 79,888 shares in Core Laboratories N.V. , the firm said in a disclosure report filed with the SEC on Aug 2, 2016.Core Laboratories N.V. makes up approximately 2.67% of Mcdonald Capital Investors Incca’s portfolio.

Other Hedge Funds, Including , Quantbot Technologies Lp sold out all of its stake in CLB during the most recent quarter. The investment firm sold 9,595 shares of CLB which is valued $1,088,937.Zurcher Kantonalbank (zurich Cantonalbank) boosted its stake in CLB in the latest quarter, The investment management firm added 1,175 additional shares and now holds a total of 14,487 shares of Core Laboratories N.V. which is valued at $1,644,130. Core Laboratories N.V. makes up approx 0.02% of Zurcher Kantonalbank (zurich Cantonalbank)’s portfolio. Miller Howard Investments Inc Ny added CLB to its portfolio by purchasing 35,315 company shares during the most recent quarter which is valued at $4,192,597. Core Laboratories N.V. makes up approx 0.07% of Miller Howard Investments Inc Ny’s portfolio. Washington Trust Bank added CLB to its portfolio by purchasing 21 company shares during the most recent quarter which is valued at $2,542.

Core Laboratories N.V. opened for trading at $116.28 and hit $119.89 on the upside on Monday, eventually ending the session at $119.75, with a gain of 3.91% or 4.51 points. The heightened volatility saw the trading volume jump to 6,23,034 shares. Company has a market cap of $5,282 M.

On the company’s financial health, Core Laboratories N.V. reported $0.35 EPS for the quarter, based on the information available during the earnings call on Jul 20, 2016. Analyst had a consensus estimate of $0.35. The company had revenue of $148.10 million for the quarter, compared to analysts expectations of $146.21 million. The company’s revenue was down -27.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.81 EPS.

Many Wall Street Analysts have commented on Core Laboratories N.V.. JP Morgan Initiated Core Laboratories N.V. on Jun 10, 2016 to “Overweight”, Price Target of the shares are set at $120.

Core Laboratories N.V. (Core Lab) is a provider of proprietary and patented reservoir description production enhancement and reservoir management services to the oil and gas industry. These services and products are directed toward enabling its clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company operates in three segments: Reservoir Description Production Enhancement and Reservoir Management. The Company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *